<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01577576</url>
  </required_header>
  <id_info>
    <org_study_id>LOCAL/2012/APM-01</org_study_id>
    <secondary_id>2012-A00475-38</secondary_id>
    <nct_id>NCT01577576</nct_id>
  </id_info>
  <brief_title>Mechanical Stress Effects on the Cardiovascular Adaptations of Peripheral Arterial Calcifications Among Athletes</brief_title>
  <acronym>MediaSport</acronym>
  <official_title>Morphological, Biomechanical and Functional Properties of the Arterial Wall of Athletes: Impact and Consequences of Mechanical Stress on the Cardiovascular Adaptations of Peripheral Arterial Calcifications</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Nīmes</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Nīmes</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main objective of this study is to obtain data for the integrated analysis of
      morphological, functional and biomechanical parameters pertaining to lower limb arteries in
      various categories of elite athletes (without cardiovascular risk and practicing high- or
      low-impact aerobic activities which preferentially implicate lower limb activity) as compared
      to (each other and to) sedentary controls.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Secondary objectives of this study are:

      A. Determine the presence and extent of intima-media calcifications in athletes B. Determine
      the relationship between these calcifications and the level, length and intensity of sports
      activity.

      C. Determine the relationship between these properties and calcification of the arterial wall
      D. Analyze the relationship between the type of sports activity and properties of the
      arterial wall.

      E. Examine the relationship between the properties of the arterial wall and peripheral
      perfusion pressures.

      F. Examine the relationship between the properties of the arterial wall, changes in
      afterload, morphology and systolic heart function.

      G. Analyze the relationships between the parameters characterizing the arterial wall and
      muscle mass of the lower limbs.

      H. Analyze the relationship between the presence of intramural calcification and bone density
      determined by densitometry.

      I. Analyze the relationship between the presence of intramural calcification and dietary
      protein intake and calcium.

      J. Compare indices of pressure at the ankle and toe, depending on the extent of
      calcification.

      K. Create a collection of biological samples (serum).
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Inclusion curve too slow.
  </why_stopped>
  <start_date>September 2012</start_date>
  <completion_date type="Actual">March 2015</completion_date>
  <primary_completion_date type="Actual">March 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Presence / absence of intra parietal calcification of lower limb arteries</measure>
    <time_frame>Baseline (Day 0; transversal study)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Extent of intra parietal calcification of lower limb arteries</measure>
    <time_frame>Baseline (Day 0; transversal study)</time_frame>
    <description>Score ranging from 0 to 3</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inner diameter of the intima-media of the common femoral artery (mm)</measure>
    <time_frame>Baseline (Day 0; transversal study)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Outer diameter of the intima-media of the common femoral artery (mm)</measure>
    <time_frame>Baseline (Day 0; transversal study)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inner diameter of the intima-media of the superficial femoral artery (mm)</measure>
    <time_frame>Baseline (Day 0; transversal study)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Outer diameter of the intima-media of the superficial femoral artery (mm)</measure>
    <time_frame>Baseline (Day 0; transversal study)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inner diameter of the intima-media of the common carotid artery (mm)</measure>
    <time_frame>Baseline (Day 0; transversal study)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Outer diameter of the intima-media of the common carotid artery (mm)</measure>
    <time_frame>Baseline (Day 0; transversal study)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Thickness of the intima-media of the common femoral artery (mm)</measure>
    <time_frame>Baseline (Day 0; transversal study)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Thickness of the intima-media of the superficial femoral artery (mm)</measure>
    <time_frame>Baseline (Day 0; transversal study)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Thickness of the intima-media of the common carotid artery (mm)</measure>
    <time_frame>Baseline (Day 0; transversal study)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Local parietal compliance of the superficial femoral artery</measure>
    <time_frame>Baseline (Day 0; transversal study)</time_frame>
    <description>mm^2/mmHg</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Compliance of the carotid artery</measure>
    <time_frame>Baseline (Day 0; transversal study)</time_frame>
    <description>mm^2/mmHg</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Distensibility of the carotid artery</measure>
    <time_frame>Baseline (Day 0; transversal study)</time_frame>
    <description>mmHg^-1*10^-2</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Arterial wave velocity in lower limb</measure>
    <time_frame>Baseline (Day 0; transversal study)</time_frame>
    <description>m/s</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Arterial wave velocity in upper limb</measure>
    <time_frame>Baseline (Day 0; transversal study)</time_frame>
    <description>m/s</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Endothelium-dependent vasorelaxation in the femoral artery</measure>
    <time_frame>Baseline (Day 0; transversal study)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postischemic vasomotor response at the (skin) microcirculatory level</measure>
    <time_frame>Baseline (Day 0; transversal study)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Systolic pressure index at the ankle</measure>
    <time_frame>Baseline (Day 0; transversal study)</time_frame>
    <description>relative units</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Systolic pressure index for the big toe</measure>
    <time_frame>Baseline (Day 0; transversal study)</time_frame>
    <description>relative units</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiac afterload index</measure>
    <time_frame>Baseline (Day 0; transversal study)</time_frame>
    <description>g/cm^2</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Echocardiographic parameters analyzing systolic function: the stroke volume</measure>
    <time_frame>Baseline (Day 0; transversal study)</time_frame>
    <description>ml</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Echocardiographic parameters analyzing systolic function: cardiac output</measure>
    <time_frame>Baseline (Day 0; transversal study)</time_frame>
    <description>l/min</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Echocardiographic parameters analyzing systolic function: peripheral vascular resistance</measure>
    <time_frame>Baseline (Day 0; transversal study)</time_frame>
    <description>Pa.s/m^3</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Echocardiographic parameters analyzing systolic function: fractional shortening</measure>
    <time_frame>Baseline (Day 0; transversal study)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Echocardiographic parameters analyzing systolic function: speed of the S-wave according to tissue Doppler</measure>
    <time_frame>Baseline (Day 0; transversal study)</time_frame>
    <description>cm.s-1</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Echocardiographic parameters analyzing systolic function: global longitudinal strain</measure>
    <time_frame>Baseline (Day 0; transversal study)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ventricular-arterial coupling</measure>
    <time_frame>Baseline (Day 0; transversal study)</time_frame>
    <description>relative units</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Echocardiographic parameters analyzing diastolic function: transmitral E wave velocity</measure>
    <time_frame>Baseline (Day 0; transversal study)</time_frame>
    <description>cm/s</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Echocardiographic parameters analyzing diastolic function: transmitral A wave velocity</measure>
    <time_frame>Baseline (Day 0; transversal study)</time_frame>
    <description>cm/s</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Echocardiographic parameters analyzing diastolic function: transmitral E wave velocity / transmitral A wave velocity</measure>
    <time_frame>Baseline (Day 0; transversal study)</time_frame>
    <description>relative units</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Echocardiographic parameters analyzing diastolic function: maximum Em wave velocity according to tissue Doppler</measure>
    <time_frame>Baseline (Day 0; transversal study)</time_frame>
    <description>cm/s</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Echocardiographic parameters analyzing diastolic function: maximum Am wave velocity according to tissue Doppler</measure>
    <time_frame>Baseline (Day 0; transversal study)</time_frame>
    <description>cm/s</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Echocardiographic parameters analyzing diastolic function: transmitral E wave velocity / maximum Em wave velocity according to tissue Doppler</measure>
    <time_frame>Baseline (Day 0; transversal study)</time_frame>
    <description>relative units</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Echocardiographic parameters analyzing diastolic function: early diastolic strain-rate</measure>
    <time_frame>Baseline (Day 0; transversal study)</time_frame>
    <description>s^-1</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Years of athletic training</measure>
    <time_frame>Baseline (Day 0; transversal study)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hours of athletic training per week</measure>
    <time_frame>Baseline (Day 0; transversal study)</time_frame>
    <description>h/week</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Best performance in the last 6 months</measure>
    <time_frame>Baseline (Day 0; transversal study)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lower limb muscle mass</measure>
    <time_frame>Baseline (Day 0; transversal study)</time_frame>
    <description>g</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bone density</measure>
    <time_frame>Baseline (Day 0; transversal study)</time_frame>
    <description>g/cm^2</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dietary protein intake</measure>
    <time_frame>Baseline (Day 0; transversal study)</time_frame>
    <description>g/day</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dietary protein intake</measure>
    <time_frame>Baseline (Day 0; transversal study)</time_frame>
    <description>% calories per day</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dietary calcium intake</measure>
    <time_frame>Baseline (Day 0; transversal study)</time_frame>
    <description>mg/day</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum protein</measure>
    <time_frame>Baseline (Day 0; transversal study)</time_frame>
    <description>g/l</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum calcium</measure>
    <time_frame>Baseline (Day 0; transversal study)</time_frame>
    <description>mmol/l</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum phosphorus</measure>
    <time_frame>Baseline (Day 0; transversal study)</time_frame>
    <description>mmol/l</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum parathyroid hormone</measure>
    <time_frame>Baseline (Day 0; transversal study)</time_frame>
    <description>ng/l</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum vitamin D2</measure>
    <time_frame>Baseline (Day 0; transversal study)</time_frame>
    <description>µg/l</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum vitamin D3</measure>
    <time_frame>Baseline (Day 0; transversal study)</time_frame>
    <description>µg/l</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">56</enrollment>
  <condition>Monckeberg Medial Calcific Sclerosis</condition>
  <arm_group>
    <arm_group_label>Upper-body athletes</arm_group_label>
    <description>This group includes swimmers, rowers or kayakers with a history of at least 10 years of intense training, and performance in regional competitions for the past five years.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lower-body athletes</arm_group_label>
    <description>This group includes runners (marathon or trail) and cyclists with a history of at least 10 years of intense training, and performance in regional competitions for the past five years.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sedentary volunteers</arm_group_label>
    <description>This group of healthy volunteers does not participate in athletic activity for more than two hours per week. They are matched by age and sex with the athletic groups.</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      A non-fasting venous blood sample is required for the following cofactors:

        -  serum protein

        -  serum calcium

        -  phosphorus

        -  PTH

        -  Vitamin D2 and D3

      Left-over serum will be stored in the Nîmes University Hospital &quot;Sérotheque&quot; (serum
      collection).
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        The study population is composed of three groups of healthy volunteers: (1) high impact
        lower-limb sports (marathon or trail); (2) low-impact lower-limb sports and (3) sedentary
        volunteers. All volunteers are between the ages of 25 and 40.

        The groups will be matched by age and sex. Athletic groups will be matched according to
        years of intensive practice and hours of training.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria for athletic and sedentary volunteers:

          -  The volunteer must have given his/her informed and signed consent

          -  The volunteer must be insured or beneficiary of a health insurance plan

          -  Volunteers without cardiovascular disease, glucose regulation disorders or known renal
             disease

        Inclusion Criteria for athletic volunteers only:

          -  Ongoing athletic activity for the past 10 years

          -  Athletic activity at the regional level for the past 5 years

          -  Practices one of the three following sports: marathon, trail running, cycling.

        Exclusion Criteria for athletic and sedentary volunteers:

          -  The volunteer is participating in another study

          -  The volunteer is in an exclusion period determined by a previous study

          -  The volunteer is under judicial protection, under tutorship or curatorship

          -  The volunteer refuses to sign the consent

          -  It is impossible to correctly inform the volunteer

          -  The volunteer is pregnant, parturient, or breastfeeding

          -  Tobacco use

          -  Contraindications for the practice of physical activity (joint, heart or other)

          -  Intercurrent pathology

          -  First degree family history of cardiovascular disease

          -  Known dyslipidemia (including cholesterol)

          -  Glucose tolerance abnormalities (prediabetes or diabetes)

          -  Treatment with certain drugs used for treating erectile dysfunction: Sildefanil
             (Viagra), Tadalafil (Cialis), Vardenafil (Levitra) and yohimbine (Yohimbine Houde and
             Yocoral)

        Exclusion Criteria for sedentary volunteers only:

          -  More than two hours of athletic activity per week

          -  History of intense athletic training

          -  Body mass index &gt;= 25 kg/m^2
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Antonia Perez Martin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Hospitalier Universitaire de Nîmes</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Université d'Avignon, Faculté des Sciences</name>
      <address>
        <city>Avignon</city>
        <zip>84000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de Nîmes - Hôpital Universitaire Carémeau</name>
      <address>
        <city>Nîmes Cedex 09</city>
        <zip>30029</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 12, 2012</study_first_submitted>
  <study_first_submitted_qc>April 13, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 16, 2012</study_first_posted>
  <last_update_submitted>November 27, 2015</last_update_submitted>
  <last_update_submitted_qc>November 27, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 30, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Athletes</keyword>
  <keyword>Sedentary volunteers</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Calcinosis</mesh_term>
    <mesh_term>Monckeberg Medial Calcific Sclerosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

